Stay updated on Poloxamer 188 in Sickle Cell Vaso-Occlusion Clinical Trial
Sign up to get notified when there's something new on the Poloxamer 188 in Sickle Cell Vaso-Occlusion Clinical Trial page.

Latest updates to the Poloxamer 188 in Sickle Cell Vaso-Occlusion Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedPublications section now notes that publications are automatically filled from PubMed, replacing the previous wording. Revision updated from v3.2.0 to v3.3.2.SummaryDifference0.1%

- Check28 days agoChange DetectedThe funding-status notice on the page was removed. The study record content and navigation remain unchanged.SummaryDifference0.2%

- Check42 days agoChange DetectedMinor layout and styling adjustments observed; core study content and the list of locations appear unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check71 days agoChange DetectedAdded a government funding status notice and a new version tag (v3.2.0); removed a specific resource (Hb SS disease) and the previous version tag (v3.1.0).SummaryDifference4%

- Check78 days agoChange DetectedUpdate of chemical/material taxonomy and nomenclature, with a new revision tag (v3.1.0) replacing older terms from v3.0.2.SummaryDifference1%

- Check93 days agoChange DetectedRevision: v3.0.2 added, replacing v3.0.1; the 'Back to Top' link was removed.SummaryDifference0.2%

Stay in the know with updates to Poloxamer 188 in Sickle Cell Vaso-Occlusion Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Poloxamer 188 in Sickle Cell Vaso-Occlusion Clinical Trial page.